Upcoming efficacy trial illustrates the value of African-led science - IAVI. IAVI is a nonprofit scientific research organization dedicated to addressing urgen
In the midst of a pandemic and preparing for the next - IAVI. SARS-CoV-2 is the first Disease X. There will certainly be others. Will the world be better prepar
IAVI REPORT – VOL. 23, NO. 1, 2019 - IAVI. In 2007, I was in Cape Town to attend a symposium on the challenges of global vaccine development. At that meeting, a
Overflowing with antibodies and optimism - IAVI. This overarching sense of optimism was palpable when thousands of researchers gathered in Madrid, Spain, this O
A Mean Flu Season Swings a Spotlight on Vaccines - IAVI. As this particularly severe flu season winds down in the Northern hemisphere, parents, doctors, and sci